372-47750-69103

2 vaccinations 6 coded responses 21 check-ins 6 free-text entries 4 call cases

Sex: Female
Age at first dose: 66+
ZIP prefix: 952 / CA
Registered: 2021-04-06

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
1549442 (opens in a new window)	high	10 / 11	-3	2 of 5 VAERS symptoms	same dose (2)	CA matches	2021-05-04 / 2021-05-05 / 2021-08-12 received the same day as the last call	case 906116

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-06
Registered in v-safe
2021-04-06
Dose 1 — Pfizer-BioNTech
2021-04-06
Health check-in — day 0, dose 1
Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-07
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-08
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2021-04-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Redness, Itching · Muscle or body aches

Adult check-in
2021-04-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Itching · None

Adult check-in
2021-04-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-13
Health check-in — day 7, dose 1
Feeling: Good · Site: Itching · None

Adult check-in
2021-04-21
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-27
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-05-04
Dose 2 — Pfizer-BioNTech
2021-05-06
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site induration — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Hardness on injection site

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-07
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-05-08
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Itching · Joint pains, Muscle or body aches

Adult check-in
2021-05-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Rash, not including the immediate area around the injection site

Adult check-in
2021-05-12
Health check-in — day 7, dose 2
Feeling: Good · Headache, Joint pains, Muscle or body aches

Adult check-in
2021-05-18
Survey response — day 14, dose 2
MedDRA: Arthralgia, Injection site pruritus, Injection site rash, Myalgia — Feeling: Fair

Free text: Skin rash above injection site persists with itching. Joint & muscular pain also persist.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-26
Survey response — day 21, dose 2
MedDRA: Injection site pruritus, Injection site rash, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional

Free text: Symptoms: Itching at site of injection. Persistent rash above the injection site. · Healthcare visit (other): PCP & Dermatologist appts in June & July, respectively.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-26
Report sent to call center — day 21, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-01
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-06-08
Survey response — day 35, dose 2
MedDRA: Rash, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional

Free text: Symptoms: Skin rashes · Healthcare visit (other): Scheduled appt July 20 with dermatologist

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-08
Report sent to call center — day 35, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-15
Survey response — day 42, dose 2
MedDRA: Asthenia, Fatigue, Injection site rash, Office visit, Rash — Feeling: Good · Get care from a doctor or other healthcare professional

Free text: Symptoms: 1. Persistent skin rash above injection site2. Fatigue3. Weakened · Healthcare visit (other): Dermatologist appt. in July

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-15
Report sent to call center — day 42, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-21
Call 1 — Left Voicemail
2021-08-03
Survey response — 3 months, dose 2
MedDRA: Actinic keratosis, Asthma, Office visit, Seborrhoeic keratosis, Skin lesion, Squamous cell carcinoma — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: #1) After 2nd vaccination of Pfizer, appearance of multiple skin lesions on arms, shins, face and hands of actinic keratoses (on arms), squamous cell carcinoma (on face) & seborrheic keratoses (all over body (mainly thighs & legs)#2) asthma · Healthcare visit (other): Appt w/dermatologist & pulmonologist

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-03
Report sent to call center — 3 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-12
Call successful
Completed over the phone
2021-11-02
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-06	Pfizer-BioNTech
2	2021-05-04	Pfizer-BioNTech

Call center

4 call center cases

4 successful

VAERS report filed, before or during a call: 4

See the call center timeline

Free text

Release 8 — days 1–6 daily, dose 2

2021-05-06

Systemic reaction (other): Hardness on injection site

Release 8 — day 14, dose 2

2021-05-18

Symptoms: Skin rash above injection site persists with itching. Joint & muscular pain also persist.

Release 8 — day 21, dose 2

2021-05-26

Symptoms: Itching at site of injection. Persistent rash above the injection site.

Healthcare visit (other): PCP & Dermatologist appts in June & July, respectively.

Release 8 — day 35, dose 2

2021-06-08

Symptoms: Skin rashes

Healthcare visit (other): Scheduled appt July 20 with dermatologist

Release 9 — day 42, dose 2

2021-06-15

Symptoms: 1. Persistent skin rash above injection site2. Fatigue3. Weakened

Healthcare visit (other): Dermatologist appt. in July

Release 9 — 3 months, dose 2

2021-08-03

Symptoms: #1) After 2nd vaccination of Pfizer, appearance of multiple skin lesions on arms, shins, face and hands of actinic keratoses (on arms), squamous cell carcinoma (on face) & seborrheic keratoses (all over body (mainly thighs & legs)#2) asthma

Healthcare visit (other): Appt w/dermatologist & pulmonologist

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	✓	✓	✓
HCVO	Unevaluable event	✓	✓	✓
SD	Actinic keratosis	✓	·	✓
SD	Arthralgia	✓	✓	✓
SD	Asthenia	✓	✓	✓
SD	Asthma	✓	·	✓
SD	Fatigue	✓	✓	✓
SD	Injection site pruritus	✓	✓	✓
SD	Injection site rash	✓	✓	✓
SD	Myalgia	✓	✓	✓
SD	Rash	✓	✓	✓
SD	Seborrhoeic keratosis	✓	·	✓
SD	Skin lesion	✓	·	✓
SD	Squamous cell carcinoma	✓	·	✓
SRO	Injection site induration	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release